Aspirin's benefits and harms are less clear for primary prevention in moderate-risk patients (ARRIVE)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Aspirin's Benefits and Harms Are Less Clear for Primary Prevention in Moderate-risk Patients (ARRIVE)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314660/all/images/google-play-badge.png.
Aspirin's benefits and harms are less clear for primary prevention in moderate-risk patients (ARRIVE). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314660/all/images/google-play-badge.png. Accessed May 25, 2024.
Aspirin's benefits and harms are less clear for primary prevention in moderate-risk patients (ARRIVE). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314660/all/images/google-play-badge.png
Aspirin's Benefits and Harms Are Less Clear for Primary Prevention in Moderate-risk Patients (ARRIVE) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 May 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314660/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aspirin's benefits and harms are less clear for primary prevention in moderate-risk patients (ARRIVE)
ID - 1314660
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314660/all/images/google-play-badge.png
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -